Anemia is a common symptoms of kidney disease. Patients with anemia also
suffer from some adverse effects for patients with stage 4 kidney failure. How to deal with anemia concerns
patients and their family members most.
Anemia may develop due to inadequate synthesis of erythropoietin by the
kidneys, and may worsen as CKD progresses. People with diabetes may present with
anemia of CKD earlier than people without diabetes.
Evaluation of anemia includes:
Complete blood count (CBC)
Iron studies (serum iron, total iron binding capacity [TIBC], percent
transferrin saturation [TSAT], and serum ferritin)
Peripheral blood smear
Uncomplicated anemia of CKD is usually normocytic and normochromic.
Hemoglobin is the preferred test to assess and monitor for anemia in CKD.
Prior to therapy, other treatable causes of anemia must be ruled out. Iron
deficiency should be corrected. Both oral and parenteral iron preparations are
available.
Therapy may include erythropoiesis-stimulating agents (ESAs) to increase red
blood cell production and prevent the need for transfusion.
A Food and Drug Administration (FDA) black box warning for ESAs was released
as a result of recent trials, which showed an increased risk for stroke, blood
clot, heart attack, and death when ESAs were prescribed to achieve higher
hemoglobin goals (> 11 g/dL). FDA recommends providers consider starting ESA
therapy only when the hemoglobin level is less than 10 g/dL and both of the
following apply:
Rate of hemoglobin decline shows the patient may require a red blood cell
transfusion and reduction of risk of alloimmunization and/or other red blood
cell transfusion-related risk is a goal.
The main function of Micro-Chinese Medicine Osmotherapy are as following:
This therapy can activate blood circulation and dredge channels. Micronized
Chinese medicine has a better effect on activating blood, dredging channels,
dilating kidney arteries as well as improving microcirculation and activating
renal inherent cells function.
This therapy can remove blood stasis and eliminating toxins in body. This
means that micronized Chinese medicine can degrade extracellular matrix (ECM)
and eliminate apoptosis cells, which can create a better internal environment.
This is also the key of the whole treatment process.
This therapy also can repair and rebuild. Active substances of Chinese
medicine can not act on fibrous tissue. But once there is remained kidney
function and healthy kidney tissue, micronized Chinese medicine can play its
role in repairing and rebuilding healthy kidney tissue and kidney function.
If you want to know more details about this natural treatment, you can send
email to kidneyhospitalabroad@hotmail.com.
没有评论:
发表评论